
Long and vast experience in pathology, in arthritis, in arthritis and systemic autoimmune diseases
Μακρόχρονη και τεράστια εμπειρία σε παθήσεις της παθολογίας, στις αρθρίτιδες και στα συστηματικά αυτοάνοσα νοσήματα από την μετεκπαίδευση και εργασία μου σε Ελλάδα, Αγγλία (United Medical and Dental Schools, Guy’s Hospital, London) και Αμερική (Temple University, Philadelphia, PA, USA).
Με την ανάληψη της Διεύθυνσης της Ρευματολογίας στο Πανεπιστημιακό Γενικό Νοσοκομείο Λάρισας από την αρχή της λειτουργίας του τo 2000, πέτυχα, με τη βοήθεια των Συνεργατών μου, να βάλω τη Ρευματολογική κλινική του νοσοκομείου στο διεθνή χάρτη και στη μεγάλη εκτίμηση των ασθενών.
Lazaros I Sakkas, MD, ECFMG(USA), DM, PhD (UK), FRCP (UK)
Specialist in Internal medicine and Rheumatology
Professor of Internal Medicine and Rheumatology, Faculty of Medicine, Shool of Health Sciences, University of Thessaly, Larissa, Greece
Formerly, Chairman, Department of Rheumatology and Clinical Immunology, University General Hospital of Larissa
ECFMG Certificate, USA
Title of Specialty in Internal Medicine, Ministry of Health, Greece
Diploma in vascular diseases, Helenic Angiology Society (1984)
Didactoriko (PhD) degree, National and Kappodistrian University of Athens
PhD degree, London University, London, UK
Title of Specialty in Rheumatology, Ministry of Health, Greece
After specialization in Internal Medicine (Greece).
Visitor for one month, Department of Medicine, Ottawa University General Hospital, Ottawa, Canada
Registrar in Rheumatology and Research Assistant/Associate, Rheumatology Unit, Division of Medicine, and Department of Immunogenetics, United Medical and Dental schools of Guy’s and St’Thomas’ Hospitals (UMDS), Guy’s Hospital, London SE1 UK and PhD student(1985-1991)
Assistant Professor of Medicine, Head of 3rd division, Department of Internal Medicine, University General Hospital of Ioannina, Ioannina, Greece(1991-1995)
Research Assistant Professor, Department of Medicine/Rheumatology, Temple University School of Medicine, Philadelphia, PA, USA (1994-1999)
-Head of Rheumatology Division and Head of the 2nd Department of Internal Medicine (1999-2008) and then
Chairman, Department of Rheumatology (renamed Rheumatology and Clinical Immunology) (2008-Sept 2018), University General Hospital of Larissa, Larissa, Greece
Research Associate, Rheumatology Unit and Department of Immunogenetics, United Medical and Dental Schools, Guy’s Hospital, London, UK (1986-90)
Assistant Professor, University of Ioannina Medical School, Ioannina, Greece (1990-95)
Research Assistant Professor, Temple University School of Medicine, Philadelphia, PA, USA (1994-99)
Professor, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa (1998-Sept 2018), and Chairman, Department of Rheumatology, Unversity General Hospital of Larissa
Editor, Hellenic Rheumatology and then Mediterranean Journal of Rheumatology (for many years)
Editor, Front Immunol
Editor Int J Rheumatol
Guest Editor Curr Rheumatol Rev: systemic sclerosis
Guest Editor (Bogdanos DP, Sakkas LI, Shonfeld Y) Diet and rheumatic diseases. Mediterr J Rheumatology 2020
Editorial Board member in several English language Journals
New developments in the pathogenesis of rheumatoid arthritis. Ed L.I. Sakkas, InTech
I participated as Principal Investigator in many multicenter clinical trials
Special interest in systemic autoimmune diseases, (systemic sclerosis, systemic lupus erythematosus, myositides), arthritides, T cells, B cells, HLA, cytokines, autoantibodies autoimmune diseases. Environmental factors in autoimmunity. Foremost priority is early diagnosis and early institution of the most appropriate treatment for patients with rheumatic diseases.
I gave many lectures in national and international scientific meetings, seminars, and Congresses.
Many abstracts have been presented in meetings. Mosts of there appeared as full-papers.
Synopsis: 180 English language papers, 16 English chapters in English language books, 67 Greek language papers
Citation Index:7196, h-index= 45, i10-index=119
Sakkas LI, Thouas B, Kotsou S, Apostolou A, Ioakimides D. Cervical myelopathy with ankylosing hyperostosis of the spine. Surg Neurol 1985; 24:43-6.
Sakkas LI, Thouas B, Smyrnis P, Vlahos E. Low-back pain and ochronosis.
Intern Orthop 1987; 11:19-21.
Sakkas LI, Demaine AG, Welsh KI, Panayi GS. Restriction fragment length polymorphism for the T-cell receptor α and β chain genes in rheumatoid arthritis.
Arthritis Rheum 1987; 30:231-2.
Wordsworth BP, Lanchbury JSS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the human leukocyte antigen class II region.
Proc Natl Acad Sci (USA) 1989;86: 10049-53.
Sakkas LI, Loqueman N, Panayi GS, Myles AB, Welsh KI. Immunogenetics of polymyalgia rheumatica. Br J Rheumatol 1990; 29:331-4. This prompted an editorial (BJR 29:321-4)
Sakkas LI, Vaughan RW, Panayi GS, Welsh KI. The application of polymerase chain reaction (PCR) to HLA-C locus typing. Eur J Immunogenet 1991;18: 185-87.
Sakkas LI, Marchesoni A, Kerr L-A, Ranza R, Colombo B, Welsh KI, Panayi GS. Immunoglobulin heavy chain gene polymorphisms in Italian patients with psoriasis and psoriatic arthritis. Br J Rheumatol 1991;30: 449-50.
Sakkas LI, Chikanza IC, Vaughan RW, Welsh KI, Panayi GS. Gold-induced nephropathy in rheumatoid arthritis and HLA class II genes. Ann Rheum Dis 1993;52: 300-1.
Sakkas LI, Kistis C, Akritidis NK. Anti-neutrophil cytoplasmic autoantibodies in HIV infection. Am J Kidney Dis 1994;24: 731.
Sakkas LI, Platsoucas CD. Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC. Immunol Res 1995;14: 218-36.
Akritidis NK, Sakkas LI. Adult onset Still’s disease in Greece-16 cases.
Presse Med 1995; 24(26): 1207-8.
Sakkas LI, Moore D, Akritidis NK. Cancer in families with systemic sclerosis.
Am J Med Sci 1995;310: 223-25.
Akritidis N, Yannakakis Y, Sakkas L. Very high serum ferritin levels in adult onset Still’s disease. Br J Rheumatol 1997;36: 608-9.
Sakkas LI, Johanson NA, Scanzello CR, Platsoucas CD. Interleukin 12 is expressed by infiltrating macrophages and synovial lining cells in rheumatoid arthritis and osteoarthritis. Cell Immunol 1998;188: 105-10.
Sakkas LI, Scanzello CR, Katsetos CD, Johanson NA, Burkholder J, Mitra A, Salgame P, Platsoucas CD. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol 1998;5: 430-37. This prompted an editorial.
Sakkas LI, Tourtellotte C, Berney S, Myers AR, Platsoucas CD. Increased levels of alternatively spliced interleukin-4(IL-4δ2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis. Clin Diagn Lab Immunol 1999;6: 660-66. This prompted an editorial.
Chikanza IC, Sakkas L. Advances in the therapy of rheumatoid arthritis with biological agents. Expert Opinion on Emerging Drugs 2000;5: 367-84.
Xu B, Sakkas LI, Slachta C, Jeevanandam V, Goldman B, Oleszack E, Platsoucas CD. Apoptosis in chronic rejection of human cardiac allografts. Transplantation 2001;71: 1137-46.
Sakkas LI, Platsoucas CD. Role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum 2002; 46: 3112-13.
Sakkas LI, Xu B, Artlett CA, Lu S, Jimenez SA, Platsoucas CD. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002;168: 3649-59.
Derk CT, Sakkas LI, Rasheed M, Artlet C, Jimenez SA. Autoantibodies in patients with systemic sclerosis and cancer: a case control study. J Rheumatol 2003;30: 1994-6.
Xu B, Sakkas LI, Goldman BI, Jeevandam V, Gaughan J, Oleszak EL, Platsoucas CD. Identical α-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection. Cell Immunol 2003;225: 70-85.
Sakkas LI, Koussidis G, Avgerinos E, Platsoucas CD. Decreased expression of CD3ζ-chain in T cells infiltrating the synovial membrane of patients with osteoarthritis. Clin Diagn Lab Immunol 2004;11: 195-202.
Sakkas LI, Platsoucas CD. Is systemic sclerosis an antigen-driven T cell disease? Arthritis Rheum 2004; 50: 1721-33.
Kalogirou A, Gelou E, Mountantonakis S, Settas L, Zafiriou E, Sakkas LI. Early T cell activation in the skin from patients with systemic sclerosis. Ann Rheum Dis 2005;64:1233-35.
Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity 2005;38:113-16. Editorial.
Sakkas LI, Chikanza IC, Platsoucas CD. Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nature Clin Pract Rheum 2006;2: 679-85 This is the 6th most read paper in 2006
Sakkas LI, Platsoucas CD. The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum 2007;56:409-24.
Alexiou I, Germenis A, Ziogas A, Theodoridou K, Sakkas LI. Diagnostic value of anti-citrullinated peptide antibodies in Greek patients with rheumatoid arthritis. BMC Musculoskel Dis 2007;8: 37-43
Sakkas LI, Boulbou M, Kyriakou D, Makri I, Sinani C, Germenis A, Stathakis N. Immunological features in visceral leishmaniasis may mimic systemic lupus erythematosus. Clin Biochem 2008;41:65-68
Alexiou I, Germenis A, Koutroumbas A, Kontogianni A, Theodoridou K, Sakkas LI. Anti-cyclic citrullinated peptide-2(CCP2) antibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 2008;27:511-3
Davas EM, Alexiou I, Boulbou M, Koutroumpas A, Makaritsis K, Stathakis N, Sakkas LI. Co-morbidities increase the risk of serious infections in patients with rheumatoid arthritis treated with TNFa inhibitors. J Infect 2008;57:418-20
Sakkas LI, Davas EM, Kapsalaki E, Boulbou M, Makaritsis K, Alexiou I, Tsikrikas T, Stathakis N. Haematogenous spinal infection in central Greece. Spine 2009;34:E513-8
Vlychou M, Koutroumpas A, Malizos K, Sakkas LI. Ultrasonographic evidence of inflammation is frequent in hands of patients with erosive osteoarthritis. Osteoarthritis and Cart. 2009;17: 1283-7.
Koutroumbas A, Alexiou I, Vlychou M, Sakkas LI. Comparison of clinical and ultrasonographic assessment in patients with erosive osteoarthritis. Clin Rheumatol. 2010;29:511-6
Anagnostopoulos I, Zintzaras E, Alexiou I, Papathanasiou AA, Davas E, Koutroumpas A, Barouta G, Sakkas LI. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 2010;11:98-106.
Koutroumpas A, Ziogas A, Alexiou I, Barouta G, Sakkas LI. Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease. Clin Rheum 2010; 29:1167-8.
Vlychou Μ, Koutroumpas Α, Alexiou Ι, Fezoulidis Ι, Sakkas LI. High-resolution Ultrasonography and 3.0T Magnetic Resonance Imaging in erosive and nodal hand osteoarthritis: high frequency of erosions in nodal osteoarthritis. Clin Rheum 2013;32(6):755-62
Sakkas LI, Alexiou I, Simopoulou T, Vlychou M. Enthesitis in psoriatic arthritis. Semin Arthritis Rheum 2013;43(3):325-34
Mavropoulos A, Rigopoulou EI, Liaskos C, Bogdanos DP, Sakkas LI. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Develop Immunol 2013;2013:569751
Koutroumpas A, Giannoukas A, Zintzaras E, Exarchou E, Baliakos A, makaritsis K, Sakkas LI. Erosive hand osteoarthritis is associated with subclinical atherosclerosis and endothelia cell dysfunction. Int J Biomed Sci 2013; 9(4):217-23
Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD. Citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment. Autoimmun Rev 2014;13(11):1114-20.
Sakkas LI. Editorial. Mediterranean journal of Rheumatology: New title, new look, new targets.
Sakkas LI, Vaiopoulos G. The new 2013 ACR/EULAR classification criteria for systemic sclerosis pave the way for treatment in pre-scleroderma patients. Mediterr J Rheumatol 2015;26:15-6
Sakkas LI, Mavropoulos A, Bogdanos DP. Regulatory B cells open new therapeutic strategies for autoimmune diseases. Mediterr J Rheumatol 2015;26:64-67
Simopoulou T, Varna A, Dailiana Z, Katsiari C, Alexiou I, Basdekis G, Malizos KN, Sakkas LI. Tuberculous pyomyositis; a re-emerging entity of many faces. Clin Rheumatol 2016;35:1105-10.
Mavropoulos A, Simopoulou T, Varna A, Liaskos C, Katsiari C, Bogdanos DP, Sakkas LI. B regulatory cells are numerically decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheumatol. 2016;68(2): 494-504.
Sakkas LI, Bogdanos DP. Systemic sclerosis: new evidence re-enforces the role of B cells.. Autoimmun Rev 2016;15(2):155-61
Sakkas LI, Daoussis D, Liossis S-NC, Bogdanos DP. Regulatory B cells: New players in rheumatic diseases. Clin Rev Allergy Immunol 2016.
Sakkas LI. Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis: the evidence todate. Drug Des Dev Ther 2016;10: 2723-28.
Sakkas LI, Perricone C, Bogdanos DP. Rheumatoid arthritis: an interplay of genetic and environmental factors. J Immunol Res.
Sakkas LI, Bogdanos DP. Infections as a cause of autoimmune rheumatic diseases. Auto Immun Highlights 2016;7(1):13
Sakkas LI. Regulatory B cells in autoimmune rheumatic diseases. Mediterr J Rheumatol 2017;28:27-31.
Sakkas LI, Bogdanos DP. Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data. Autoimmun Rev 2017;16(1):10-15. Doi:10.1016/j.autrev.2016.09.015.
Botou A, Bangeas A, Alexiou I, Sakkas LI. Acro-osteolysis. Clin Rheumatol 2017;36(1):9-14
Marou E, Liaskos C, Simopoulou T, Efthymiou G, Dardiotis E, Katsiaric C, Scheper T, Meyer W, Hadjigeorgiou G, Bogdanos DP, Sakkas LI. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV positive patients with systemic sclerosis. Clin Rheumatol 2017;36(4):863-69.
Bogdanos DP, Sakkas LI. From microbiome to infetome in autoimmunity. Curr Opin Rheum 2017;29(4):369-73.
Mavropoulos A, Varna A, Zafiriou E, Alexiou I, Roussaki-Shulze A, Katsiari C, Bogdanos DP, Sakkas LI. IL-10-producing ells are impared in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNγ-producing T ccells. Clin Immunol 2017;184:33-41.
Sakkas LI, Mavropoulos A, Bogdanos DP. Phosphodiesterase 4 inhibitors in immune mediated diseases: mode of action, clinical applications, future perspectives. Curr Med Chem 2017;24(28):3054-67.
Liaskos C, Marou E, Simopoulou T, Barmakoudi M, Efthimiou G, Scheper T, Meyer W, Bogdanos DP, Sakkas LI. Disease-related autoantibody profile in patients with systemic sclerosis. Autoimmunity 2017;50(7):414-21.
Sakkas LI, Daoussis D, Liossis S-N, Bogdanos DP. The infectious basis of ACPA-positive rheumatoid arthritis. Front Microbiol 2017;8:1853
Kelepouri D, Mavropoulos A, Bogdanos DP, Sakkas LI. The role of flavonoids in inhibiting Th17 responses in inflammatory arthritis. J Immunol Res 2018;2018:9324357
Sakkas LI, Simopoulou T, Daoussis D, Liossis S-N, Potamianos S. Intestinal involvement in systemic sclerosis. A clinical review. Dig Dis Sci 2018;63(4):834-44.
Sakkas LI, Bogdanos DP. Multiple hit infection and autoimmunity: the dysbiotic microbiota-ACPA connection in rheumatoid arthritis. Curr Opin Rheum 2018;30(4):403-409.
Simopoulou T, Klimopoulos S, Sampaziotis D, Tzotrziotis A, Bogdanos DP, Sakkas LI. Retroperitoneal IgG4-related disease causing inferior vena cava thrombosis: case report and literature review. JSRD 2018;
Sakkas LI, Mavropoulos A, Perricone C, Bogdanos DP. IL-35: a new immunoregulator in autoimmune rheumatic diseases. Immunol Res 2018;66(3):305-312.
Katsiari C, Simopoulou T, Alexiou I, Sakkas LI. Immunotherary of scleroderma. Hum Vaccines Immunother 2018;14(11):2559-67
Asteriou E, Gkoutzourelas A, Mavropoulos A, Katsiari C, Sakkas LI, Bogdanos DP. Curcumin for the Management of Periodontitis and Early ACPA-Positive Rheumatoid Arthritis: Killing Two Birds with One Stone. Nutrients 2018 Jul 16;10(7).
Gkoutzourelas A, Liaskos C, Mytilinaiou MG, Simopoulou T, Katsiari C, Tsirogianni A, Daoussis D, Liossis S-N, Scheper T, Meyer W, Bogdanos DP, Sakkas LI. Anti-Ro60 seropositivity determines anti-Ro52 epitope mapping in patients with systemic sclerosis, Front Immunol 2018;9:2835.
Sakkas LI, Daoussis D, Mavropoulos A, Liossis S-N, Bogdanos DP. Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases. Semin Arthritis Rheum 2019;48(6):1133-1141.
Katsiari CG, Bogdanos DP, Sakkas LI. Inflammation and cardiovascular disease. World J Transl Med 2019;8(1):1-8
Sakkas LI, Trontzas P. The Greek (Hellenic) rheumatology over the years: From ancient to modern times. Rheumatol Int 2019
Liaskos C, Rentouli S, Simopoulou T, Gkoutzourelas A, Norman GL, Brotis A, Alexiou I, Katsiari C, Bogdanos DP, Sakkas LI. Anti-C1q autoantibodies are frequently detected in patients with systemic sclerosis associated with pulmonary fibrosis. Br J Dermatol. 2019 Jul;181(1):138-146. doi: 10.1111/bjd.17886
Mavropoulos A, Zafiriou E, Simopoulou T, Brotis AG, Liaskos C, Roussaki-Schulze A, Katsiari CG, Bogdanos DP, Sakkas LI. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis. Rheumatology (Oxford). 2019;58(12):2240-2250. doi: 10.1093/rheumatology/kez204
Sakkas LI, Zafiriou E, Bogdanos DP. New treatments in psoriatic arthritis. Focus on the IL-23/IL-17 axis. Front Pharmacol 2019;10:872.
Efthymiou G, Dardiotis E, Liaskos C, Marou E, Scheper T, Meyer W, Daponte A, Daoussis D, Hadjigeorgiou G, Bogdanos DP, Sakkas LI. A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis. Clin Immunol. 2019;207: 87-96
Gkoutzourelas A, Bogdanos DP, Sakkas LI. Kawasaki disesae and COVID-19. Mediter J Rheumatol 2020;31(Suppl 2):268-74
Stamatis P, Bodganos DP, Sakkas LI. Upadacitinib tartrate for rheumatoid arthritis. Drugs Today(Barc) 2020;56(11):723-32.
Sakkas LI, Bogdanos DP. The role of T cells in systemic sclerosis: An update. IMMUNO 2022;2: 534-47.
Sakkas LI, Katsiari C, Daoussis D, Bogdanos DP. The role of B cells in the pathogenesis of systemic sclerosis: an update. This prompted an Editorial. Rheumatology 2023
Sakkas LI, Chikanza IC. Editorial.Sex bias in immune responses: It is time to include the sex variable in studies of autoimmune rheumatic diseases Rheumatol Int 2023
